Abstract
To date, virus-mediated gene transfer has focused principally on murine leukemia virus and adenovirus as delivery vehicles (1,2). It has become clear that these viral delivery systems are not adequate for the range of potential therapeutic needs, and other vehicles are being developed for these purposes, including adeno-associated virus, herpesvirus, and others (3,4). Each virus has advantages and disadvantages: The latter include inactivation by human complement, limited infectivity, low titers, short-lived expression, immunogenicity, contamination by replication-competent or helper virus, and so on.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vile, R. G. and Russell, S. J. (1995) Retroviruses as vectors. Br. Med. Bull. 51, 12–30.
Brody, S. L. and Crystal, R. G. (1994) Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716, 90–101.
Kotin, R. M. (1994) Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793–801.
Glorioso, J. C., Goins, W. F., Fink, D. J., and DeLuca, N. A. (1994) Herpes simplex virus vectors and gene transfer to the brain. Dev. Biol. Stand. 82, 79–87.
Tooze, J., ed. (1981) DNA Tumor Viruses: Molecular Biology of Tumor Viruses. 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Shah, K. and Nathanson, N. (1976) Human exposure to SV40: review and comment. J. Epidemiol. 103, 1–12.
Gooding, L. R. (1977) Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. J. Immunol. 118, 920–927.
Strayer, D. S. (1996) SV40 as an effective gene transfer vector in vivo. J. Biol. Chem. 271, 24,741–24,746.
Strayer, D. S. and Milano, J. (1996) SV40 mediates stable gene transfer in vivo. Gene Ther. 3, 581–587.
Gething, M. J. and Sambrook, J. (1981) Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene. Nature 293, 620–625.
Asano, M., Iwakura, Y., and Kawade, Y. (1985) SV40 vector with early gene replacement efficient in transducing exogenous DNA into mammalian cells. Nucleic Acids Res. 13, 8573–8586.
Eckhart, W. (1990) Polyomavirinae and their replication, in Virology, (Fields, B. N., et al., eds.), Raven, New York, pp. 1593–1607.
Gluzman, Y. (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175–182.
Rosenberg, B. H., Deutsch, J. F., and Ungers, G. E. (1981) Growth and purification of SV40 virus for biochemical studies. J. Virol. Methods 3, 167–176.
Strayer, D. S., Duan, L.-X., Owata, I., Milano, J., Bobraski, L. E., and Bagasra, O. (1997) Titering replication-defective virus for use in gene transfer. Biotechniques 22, 447–450.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Strayer, D.S. (2000). Effective Gene Transfer Using Viral Vectors Based on SV40. In: Kmiec, E.B. (eds) Gene Targeting Protocols. Methods in Molecular Biology™, vol 133. Humana Press. https://doi.org/10.1385/1-59259-215-5:61
Download citation
DOI: https://doi.org/10.1385/1-59259-215-5:61
Publisher Name: Humana Press
Print ISBN: 978-0-89603-360-3
Online ISBN: 978-1-59259-215-9
eBook Packages: Springer Protocols